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Abstract.  We report here the isolation and character- 
ization of three antisera,  each of which is specific for 
a  single keratin from one of the three different pairs 
(K1/KI0, K14/K5,  K16/K6) that are differentially ex- 
pressed in normal  human epidermis and  in epidermal 
diseases of hyperproliferation.  We have used these an- 
tisera in conjunction with monospecific cRNA probes 
for epidermal keratin mRNAs to investigate pathways 
of differentiation in human epidermis and epidermal 
diseases in vivo and in epidermal cells cultured from 
normal  skin and from squamous cell carcinomas in 
vitro.  Specifically,  our results  suggest  that:  (a) the basal- 
specific keratin mRNAs are down-regulated upon com- 
mitment to terminal  differentiation,  but their encoded 
proteins are stable, and can be detected throughout the 
spinous layers;  (b) the hyperproliferation-associated 
keratin mRNAs are expressed at a low level through- 
out normal epidermis when their encoded proteins are 
not expressed, but are synthesized at high levels in the 
suprabasal layers of hyperproliferating epidermis,  coin- 
cident with the induced expression of the hyperprolif- 
eration-associated keratins in these cells; and (c) 
concomitantly with the induction of the hyperprolifera- 
tion-associated keratins  in the suprabasal layers of the 
epidermis is the down-regulation of the expression of 
the terminal  differentiation-specific keratins.  These 
data have important  implications for our understanding 
of normal epidermal differentiation and the deviations 
from this process in the course of epidermal diseases 
of hyperproliferation. 
T 
HE normal epidermis consists of 10-20 layers whose 
cells possess distinct  structure  and  properties.  The 
cells in the basal layer proliferate;  as cells leave this 
layer and begin to migrate outward towards the skin surface, 
they cease to divide and undergo a series of biochemical and 
morphological changes that culminate  in the production of a 
tough, protective outer coat (stratum  corneum) of dead, ter- 
minally differentiated  cells.  A number of changes in protein 
synthesis take place during the process of terminal differenti- 
ation.  The major changes  are in the expression of keratins, 
a family of proteins (40-67 kD) which assemble into 8-nm 
structural  filaments in the cytoplasm of all epidermal cells. 
Basal cells express only two keratins,  K5 (58 kD) and K14 
(50 kD) (Nelson and Sun,  1983). From tissue sectioning and 
keratin extractions,  it is thought that the expression of these 
keratins  may still continue in the suprabasal  layers (Fuchs 
and Green,  1980; Woodcock-Mitchell  et al., 1982; Skerrow 
and Skerrow,  1983). In situ hybridizations  on the other hand 
have indicated  that  K14 and I(5  mRNA expression is pre- 
dominantly  basal  (Tyner  and  Fuchs,  1986;  Lersch  and 
Fuchs,  1988). 
Suprabasal  cells express K1  (67  kD), K2 (65  kD), K10 
(56.5 kD), and Kll (56 kD) (Viac et al.,  1980; Woodcock- 
Mitchell et al., 1982; Tseng et al., 1982; Skerrow and Sker- 
row, 1983; Kopan et al., 1987). While K1 and K10 arise from 
the induction  of new mRNAs, K2 and K11 appear later and 
seem to be proteolytic degradation  products of K1 and K10, 
respectively (Fuchs  and  Green,  1980;  Tyner  and  Fuchs, 
1986; Kopan et al.,  1987).  In humans,  expression of large 
keratins  is highly  restricted to keratinizing  cells of epider- 
mis, exocervix, and anus (Moll et al.,  1982a).  The shift to 
the expression of K1 and K10 is one of the earliest biochemi- 
cal indications  that a cell has undergone  a commitment to- 
wards terminal  differentiation.  The extent to which the de- 
cline in K5 and K14 synthesis and the induction  of K1 and 
K10 synthesis are linked in epidermal differentiation has not 
yet been fully evaluated. 
In the course of human epidermal diseases of hyperprolif- 
eration,  a number of different morphological and biochemi- 
cal  aberrations  have been observed. The most significant 
differences  seem to be the reduction in the expression of K1 
and K10 (Baden  et al.,  1978; Hunter and  Skerrow,  1981; 
Thaler et al., 1980; Weiss et al., 1984; McGuire et al., 1984), 
and the induction  of a new set of keratins,  K6 (56 kD) and 
KI6 (48 kD) (Weiss et al.,  1984). In normal epidermis, K6 
and K16 are only expressed transiently,  during  wound heal- 
ing  (Lane et al.,  1985;  Mansbridge and Knapp,  1987) or 
when skin is placed into tissue culture medium in vitro (Sun 
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1986). Most of  the documented abnormalities of keratin syn- 
thesis in epidermal diseases stem from studies involving pro- 
tein extraction, electrophoretic separation, or immunoblot 
analysis.  While  some  immunohistochemical studies  have 
been  attempted (Raemakers et al.,  1983;  Thomas et al., 
1984;  Leigh et al.,  1985;  Weiss et al,  1984; Knight et al., 
1985; Robinson, 1987), they have been hampered by the lack 
of monospecific antibodies against specific epidermal kera- 
tins. Thus, it has been difficult  to assess precisely which cells 
of the epidermis undergo these changes and the extent to 
which these biochemical changes might be associated with 
morphological alterations. 
In this report, we describe the preparation and character- 
ization of three antisera, each of which is specific for one of 
the three sets of epidermal keratins (basal, keratinization as- 
sociated,  and hyperproliferation associated).  Using  three 
specific epidermal keratin cRNA probes in conjunction with 
immunohistochemical localization,  we  investigate the  ex- 
pression of keratin mRNAs and keratin proteins in normal 
epidermis, and in epidermal diseases of hyperproliferation. 
We also report the use of an epidermal cell culture method 
as a  model system for studying the morphology and bio- 
chemistry of  both normal and tumor epidermal cells in vitro. 
This method involves seeding epidermal cells on a lattice of 
collagen and fibroblasts, and then floating the artificial skin 
on a raft to enable epidermal cells to be fed from beneath 
(Lillie et al.,  1980; Karasek et al.,  1971; Asselineau et al., 
1985; 1986; Kopan et al., 1987). Using this system to culture 
normal epidermal cells, and the squamous cell carcinoma 
cell lines SCC-13,  SCC-12,  and SCC-15,  we examine the 
morphological and biochemical similarities between these 
cells cultured on rafts and their in vivo counterparts. 
Materials and Methods 
Preparation of Synthetic Peptides and 
Monospecific Antibodies 
Peptides to K1, K14, and K16 were synthesized, and then coupled to keyhole 
limpet haemocyanin using glutaraldehyde (K1 and KIt) or m-maleimido- 
benzoic acid N-hydroxysuccinimide ester (K14) to produce essentially NH2- 
terminally bound peptide conjugates (Paul Sheppard, Cambridge Research 
Biochemicals Cambridge,  England).  At a  concentration of 300  ~tg/ml in 
Freund's complete adjuvant,  these conjugates were injected into 7-1b New 
Zealand White male rabbits whose sera had been pretested by immunofluores- 
cence and immunoblot analysis to make certain it contained no endogenous 
keratin antibodies. For each peptide, three rabbits were injected. After 3 wk, 
each rabbit was boosted with 300 ~tg of conjugate (mixed with Freund's in- 
complete adjuvant),  and after a  10-d period, the antisera was tested for the 
presence of keratin  antibodies.  If no  appreciable titer was obtained,  the 
animals were reboosted with 300  ~tg of conjugate every 14 d until  a strong 
positive reaction was obtained either by immunofluorescence or immunoblot 
assays. In most cases, antisera reached a maximum titer at approximately the 
fifth boost. The antiserum with the strongest and most specific titer was cho- 
sen for the analyses presented here. These antisera will be referred to as anti- 
hK1 (human K1 antiserum), anti-hK14 (human K14 antiserum), and anti-hKl6 
(human KI6 antiserum). 
Preparation of  Epidermal Raft Cultures 
Collagen lattices were prepared and seeded with human keratinocytes from 
the squamous cell carcinoma lines SCC-12, SCC-13, and SCC-15 (Wu and 
Rheinwald, 1981) as described previously (Asselineau et al.,  1985;  Kopan 
et al., 1987). Cells were grown submerged in culture medium for 1 wk, and 
then floated on metal rafts for 7-14 d before fixation and sectioning (5 i.tm). 
Antiserum Staining of 1Issue and Raft Sections 
Six squamous cell carcinomas, four basal cell carcinomas, one actinic kera- 
tosis, and three psoriatic lesions were used for the studies reported here. 
Unless otherwise  indicated,  tissue  and  raft  samples were  fixed in  4% 
paraformaldehyde, embedded in paraffin, and sectioned (5 I.tm). Most sec- 
tions were subjected to immunohistochemistry using the immunogold local- 
ization technique as described by the manufacturer, Janssen Life Sciences 
Products (Piscataway,  NJ). Briefly,  after incubation of the tissue sections 
with the rabbit anti-keratin antibodies, samples were exposed to colloidal 
gold-conjugated goat anti-rabbit secondary antibodies. Antibody staining 
was then enhanced by silver precipitation. Antisera were used at the follow- 
ing dilutions: anti-hKl4,  1:50;  anti-hK1,  1:50; anti-hK16,  1:25. 
Some of the samples were subjected to immunohistocbemistry using the 
VECTASTAIN ABC Kit as described by the manufacturer (Vector Labora- 
tories, Inc., Burlingame, CA). Briefly, the section was first exposed to pri- 
mary antibody, followed by a biotinylated secondary antibody, and then a 
preformed avidin and biotinylated alkaline phosphatase macromolecular 
complex. The enzymatic activity was localized through the use of a sub- 
strate kit  (Vector Laboratories,  Inc.),  which coupled a  soluble product 
(generated during the hydrolytic reaction) with a capture reagent, producing 
a blue insoluble precipitate. 
Epidermal and squamous cell carcinoma cultures from floating rafts were 
fixed in Carnoy's solution and subjected to immunohistochemistry using 
classical indirect immunofluorescence. In these cases, fluorescein-conju- 
gated goat anti-rabbit IgG was used as a conjugate. 
Subcloning of Coding and 3' Noncoding Keratin eDNA 
Segments into Riboprobe Vectors 
K14 eDNA Subclones.  KB-2 is a  1,410-bp eDNA insert encoding keratin 
K14 (Hanukoglu and Fuchs,  1983).  It has a single TGA stop codon posi- 
tioned at  residue  1,230. A  1,080-bp  Bste  II/Stu  I  fragment (nucleotide 
residues 170-1,250)  encompassed a major portion of the coding region of 
K14 and was subcloned into pSP65. 
K6a eDNA Subciones.  A 1,415-bp Taq I/Kpn I fragment of the 1,680-bp 
eDNA KA-1 (Hanukoglu and Fuchs,  1983;  residues 20-1,435) containing 
predominantly the coding region of K6 was subcloned into Escherichia coli 
plasmid pSP64 (Promega Biotec, Madison, WI). 
Kl6 eDNA Subclones.  The sequence for the complete gene encoding the 
human keratin K16 has been reported previously (RayChandhury et al., 
1986). To prepare a specific cDNA clone for this keratin mRNA, a 658-bp 
Pst I/Eco RI fragment containing part of intron VII, exon VIII, and the 3' 
noncoding portion of the KI6 gene was subcloned in the 3'-5' direction into 
plasmid pGEM  1 (Promega Biotec). 
Radiolabeling  of  cRNA Probes 
Cloned cDNAs were linearized, and Salmonella (SP6) or T7 RNA poly- 
merase was used to prepare 3~S-labeled cRNA probes. The method of Cox 
et al.  (1984)  was  followed as described by the manufacturer  (Promega 
Biotec). 
In Situ Hybridizations 
In situ hybridizations were performed essentially as described by Cox et al. 
(1984). Briefly, tissue sections were prepared as described above and treated 
with 1.0 I.tg/ml proteinase K for 30 min at 37°C and hybridized with 35S- 
UTP-labeled cRNA probes that had been hydrolyzed to an average size of 
150 bp by sodium carbonate treatment at 60°C. Hybridization conditions 
were: 50% recrystallized formamide, 0.3 M NaCl, 5 mM EDTA, 20 mM 
Tris-HCI, pH 8.0, 100 mM dithiothreitol (DTT), 0.02 % BSA, 0.02 % Ficoll, 
0.02%  polyvinylpyrollidone, and 10% dextran sulfate for 12 h at 41°C. Af- 
ter hybridization, tissue sections were treated with RNase to remove any un- 
hybridized probe and washed with (a) 300 mM NaCl, 30 mM sodium ci- 
trate (2x SSC) containing 10 mM DDT at 25°C for 30 min, to quench any 
nonspecific hybridization and (b) 0.1 ×  SSC containing 10 mM DTT for 1 h 
at 50°C. Autoradiography was performed using an NTB-2 Kodak emulsion. 
Samples were exposed for 3-8 d as indicated in the text. 
Results 
Design, Preparation, and Characterization of the 
Antikeratin Antisera 
Previously,  genomic  sequences  have been reported for the 
The Journal  of Cell Biology,  Volume 107, 1988  428 human epidermal keratins K1  (Johnson et al.,  1985),  K14 
(Marchuk et al.,  1984,  1985),  and K16 (RayChaudhury et 
al., 1986; Rosenberg et al., 1988). Secondary structure anal- 
yses of their predicted amino acid sequences revealed fea- 
tures characteristic of all keratins, namely a central alpha- 
helical region containing hydrophobic repeats indicative of 
an ability to form a coiled-coil structure, and the presence 
of an L L E G E sequence at the carboxy-terminal end of the 
helical region (for review, see Geisler et al., 1982; Fuchs and 
Hanukoglu, 1983;  Steinert et al.,  1985).  A comparison of 
amino acid sequences indicated that the most divergent por- 
tion of all keratin polypeptides is in the nonhelical domain 
extending from the L L E G E to the carboxy terminus. These 
sequences are also thought to protrude along the surface of 
the keratin filament (Steinert et al.,  1983). 
As haptens for the preparation of monospecific antisera, 
peptides were chosen to keratin sequences which were lo- 
cated primarily in this nonhelical carboxy-terminal domain. 
Within this region, segments which either (a) share homol- 
ogy with other known keratin sequences, or (b)  contained 
stretches of a single amino acid residue (e.g., serine) were 
avoided. 
Fig.  1 shows the sequences (underlined) which were se- 
lected for the production of synthetic peptides and for anti- 
body preparation.  Except for the K16 peptide,  the entire 
sequence chosen for peptide synthesis was also contained in 
the corresponding keratin protein. For anti-hK16,  only the 
carboxy-terminal QSS  corresponded to the KI6 sequence 
(Rosenberg et al.,  1988).  When used at a concentration of 
300  lag/ml  of antiserum,  a  synthetic heptapeptide  to  the 
carboxy-terminal sequence FSQGQSS  of the K16 protein 
quantitatively and specifically preadsorbed nearly all of the 
K16-binding activity of the antiserum. Other proteins (e.g., 
K14),  which have an  internal  QSS  sequence,  showed no 
cross-reactivity with the antiserum (data not shown). Hence, 
the free carboxyl group of the QSS sequence located at the 
terminus of the K16 protein seems to be essential to its recog- 
nition by this antiserum. 
The specificity and titers of the antisera were tested by im- 
munoblot analyses of one- and two-dimensional SDS-poly- 
acrylamide gels containing resolved keratins isolated from 
human epidermis (K1 ÷, K2  +, K5  +, K10  +, Kll ÷, K14÷), hu- 
man breast carcinoma (MCF-7)  cells (K8  ÷,  K18  ÷,  K19÷), 
and  cultured  human  epidermal  cells  (K5  +,  K6  ÷,  K13  +, 
K14  ÷, K15  ÷, K16  ÷, K17  ÷) (Fig. 2). Our results indicate that 
all three antisera are largely monospecific for their respec- 
tive keratin, with little or no cross-reactivity with any of the 
other keratins tested. Immunoblot analysis with whole cell 
extracts further verified the specificity of the antisera (not 
shown). 
Peptide Antisera Specific  for K1 and K14 Recognize 
Their Determinants in Human Skin In Vivo 
To test the usefulness of these antisera for immunohisto- 
chemistry, we prepared 4 % paraformaldehyde-fixed, paraf- 
fin-embedded sections of human forearm skin and stained 
them indirectly using the immunogold staining-silver en- 
hancement  procedure  or  the  avidin-biotinylated-alkaline 
phosphatase complex (ABC) staining procedure as described 
in Materials and Methods (Fig. 3). The anti-hK1 antiserum 
showed pronounced staining of all suprabasal layers of the 
epidermis (Fig. 3 A). This staining pattern is consistent with 
results obtained from tissue sectioning (Fuchs and Green, 
1980;  Woodcock-Mitchell et al.,  1982)  and from staining 
with broadly cross-reacting anti-s, corneum keratin antibod- 
ies (Viac et al., 1980; Tseng et al., 1982; Lane et al., 1985). 
Moreover, the suprabasal expression of  the type H keratin K1 
coincides with the suprabasal expression of its type I partner 
K10 (Raemakers et al.,  1983;  Kopan et al.,  1987). 
In contrast to the pattern of anti-hK1  staining, the staining 
of anti-hKl4 revealed abundant expression of this keratin in 
the basal epidermal layer (Fig. 3 B; in particular, note inset). 
Staining was also observed in the spinous and granular layers 
of the epidermis, although it was not quite as prominent as 
in the basal layer. While these data are in agreement with 
earlier sectioning studies (Fuchs and Green,  1980;  Wood- 
cock-Mitchell et al.,  1982),  they differ from immunohisto- 
chemical data obtained with the monoclonal anti-type I kera- 
tin antibody AE-1 (Woodcock-Mitchell et al., 1982), which 
showed only basal  staining of the epidermis.  Our results 
demonstrate clearly that K14 persists in the spinous layers, 
and confirm that the antigenic site for type I keratins that is 
recognized by AE-1 is masked in these layers. 
As expected,  no staining of normal epidermis  was ob- 
served with the anti-hK16 antiserum (Fig. 3 C). This finding 
is consistent with the fact that K16 protein has not been de- 
tected in keratin extracts from normal epidermis (Moll et al., 
1982a,  1983; Woodcock-Mitchell et al., 1982; Tseng et al., 
1982;  Tyner and Fuchs,  1986). 
KI  (67  kD):  L  L  E  G  g  g  S  R  M  ~_  E  ~_  A  ~_  N  V  S  V  T  A  S  ~_  ~_  ~_  T  S  I  S  .  .  . 
K14  C50  kD):  ..............  C  C  ~  V  V  ~_  ~  H  ~_  ~_  ~_  L  R  ~  K  ~[-COOIt 
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Figure 1. Keratin sequences selected for synthetic  peptides and anti- 
body preparations. Amino acids sequences chosen for synthetic 
peptide preparation are shown as underlined residues. Additional 
sequences are provided for reference and include either the highly 
conserved L L E G E sequence at the end of the fourth helical do- 
main of all intermediate filament proteins (shown for the human 
keratin K1) or the carboxy-terminal end of the keratin polypeptide 
(shown for the human keratins K14 and K16). For hK14, the Cys 
residue was not present in the K14 sequence, but was added for 
chemical cross-linking purposes (see Materials and Methods). For 
hK16, the sequence chosen for antibody production is shown on the 
line beneath the actual hK16 carboxy-terminal end. Note that only 
the three terminal residues of hK16 are homologous. 
Examining the Altered Pattern of  Keratin Expression 
in Hyperproliferating Epidermis 
Psoriasis is a common disease of epidermal hyperprolifera- 
tion,  characterized by the lack of a  well-defined granular 
layer and the formation of an abnormal, nucleated stratum 
corneum (referred to as parakeratinization; Fitzpatrick et al., 
1979). The degree of parakeratinization has been correlated 
with  the  degree  of abnormal  keratin  expression:  weakly 
parakeratinized tissue has a keratin pattern that resembles 
normal  epidermis  (K1 +,  K2  +,  K5  +,  K10  +,  Kll  +,  K14+), 
whereas the pattern seen in heavily parakeratinized tissue is 
almost indistinguishable from that of cultured keratinocytes 
(K5 +,  K6  +,  K14  +,  K16  +)  (Weiss  et al.,  1984).  Hence, the 
most  striking  changes  in  keratin  expression  in  psoriatic 
epidermis include a reduction in K1/K10 and an induction of 
Stoler et al. Keratin Expression in Epidermal Diseases  429 Figure 2. Immunoblot analysis of anti-hKl, anti-hKl4, and anti-hKl6.  (.4) Human intermediate  filament proteins  were extracted  from au- 
topsy skin (KI  +, K2  +, K5  +, K10  +, Kll +, K14+), cultured MCF-7 (breast carcinoma) cells (K8  +, K18  +, K19+), and cultured  epidermal cells 
(K5  +, K6  +, K13  +, K14  +, K16  +, K17+). Proteins  were loaded in this order (lanes  1-3,  respectively)  and were resolved by one-dimensional 
PAGE. Proteins  were either  visualized  by staining with  Coomassie Blue (marked  stain) or transferred  to nitrocellulose  paper  by electro- 
blotting  (Towbin et al.,  1979).  Immunoblots  were first stained with  fast green to visualize  the proteins,  and then  exposed to either  anti- 
hKl4 (¢t K14), anti-hK16 (ctKl6),  or anti-hK1 (¢tK1). After exposure to antiserum,  blots were washed and then hybridized  with  IESI-radio- 
labeled  S.  aureus  protein  A to visualize  antibody-bound  proteins.  Hybridized  blots  were  exposed  to x-ray film  for 48 h.  Keratins  were 
identified  by number according to their molecular masses and their isoelectric  mobilities  as indicated  by Moll et al.  (1982a).  Note: K6 
at left identifies  the band in the cultured cell extract  (lane 3).  K10, the band seen in the skin keratin  extract  (lane  1), has similar elec- 
trophoretic mobility to K6. (B) Coomassie Blue staining of cultured  human epidermal cell keratins,  resolved by two-dimensional  gel elec- 
trophoresis,  with a nonequilibrium pH gel in the first dimension and SDS-PAGE in the second (O'Farrell, et al., 1977). The arrow indicates 
ch~mges in isoelectric  mobilities  of keratins  due to the ability of type I and type II keratins to form complexes,  which are not fully resolved 
in the first dimension.  (C) Immunoblot of a two-dimensional  gel of cultured epidermal cell keratins  resolved as described in B and probed 
with anti-hK14 as described in A. Note that two spots were selected: one corresponding to the bona fide mobility of  KI4, and one correspond- 
ing to the complex formed between K14 and its partner K5, which was not resolved in the first dimension (see arrow in B). (D) Immunoblot 
of a two-dimensional  gel of cultured  epidermal cell keratins  resolved as described in B and probed with anti-hKl6 as described in A. Note 
that only one spot was selected,  since K16 does not form strong  complexes  with  type II keratins  (see B). 
the so called hyperproliferation-associated keratins  K6 and 
K16 (Baden  et al.,  1978;  Thaler  et al.,  1980;  Hunter  and 
Skerrow,  1981;  Matoltsy et al.,  1983; Bowden et al.,  1983; 
Weiss et al.,  1984; McGuire et al.,  1984). 
To examine how individual cells within psoriatic tissue al- 
ter their expression of keratin, we used our specific antisera 
to stain epidermis from samples of strongly parakeratinized 
psoriatic  tissues  (Fig.  4).  K1  could readily  be detected  in 
most suprabasal cells of psoriatic tissue (Fig. 4 A). However, 
staining was weaker than it was for normal epidermis, partic- 
ularly in the deeper suprabasal cells. K14 was also detected 
in psoriatic tissue (Fig. 4 B). Its localization differed slightly 
from normal epidermis in that anti-hK14 staining was seen 
in all epidermal cells, extending even to the s. corneum layer. 
Since no new protein synthesis takes place in this region of 
the skin, these data suggest that mechanisms that control pro- 
teolytic  degradation  of K14  in  the  outer  layers  of normal 
epidermis  do not function in psoriatic epidermis. 
Interestingly,  the pattern  of staining observed with anti- 
hK16 was very similar to that seen with anti-hK1, with strong 
staining in the upper spinous and granular layers of psoriatic 
tissue and none in the basal cells (Fig. 4 C). Hence a correla- 
tion seemed to exist between the reduction in the expression 
of the terminal  differentiation-specific  keratins  and the in- 
The Journal of Cell Biology, Volume  107, 1988  430 Figure 3.  Anti-keratin  staining  of normal 
human epidermis. Normal human skin (from 
biopsy) was fixed in 4% paraformaldehyde, 
sectioned (5 gm) and exposed to anti-hK1 
(A),  anti-hKl4  (B),  and  anti-hK16  (C). 
Bound antibodies  were then visualized  by 
indirect  immunohistochemistry,  using  the 
alkaline phosphatase ABC Vectastain meth- 
od (A-C) or the immunogold labeling  and 
silver enhancement technique (inset, B) as 
described in Materials  and Methods.  Sec- 
tions were  examined  by photomicroscopy. 
Note that anti-hKl4 stained  the basal epi- 
dermal layer more strongly than the supra- 
basal  layers. This is particularly evident  in 
the example  shown  in the inset  of B. Bar, 
20 ~m. 
duction of the hyperproliferation-associated keratins.  More- 
over, as judged by keratin expression,  the major alterations 
in  psoriatic  tissue  were  clearly  manifested  in  the  spinous 
layers,  rather than in the basal cells,  which still  seemed to 
possess unique structural and biochemical properties  char- 
acteristic  of normal basal  epidermal  cells. 
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epidermis.  Psoriatic  epidermis  (from  bi- 
opsy) was fixed in 4%  paraformaldehyde, 
sectioned  (5 lam) and exposed to anti-hK1 
(A),  anti-hKl4  (B),  and  anti-hKl6 (C). 
Bound antibodies were then visualized  by 
indirect immunohistochemistry,  using the 
alkaline phosphatase ABC Vectastain meth- 
od  described  in Materials  and  Methods. 
Sections  were  examined  by  photomicros- 
copy. Bar, 74 I-tm. 
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of squamous cell carcinomas. 
Tissue samples from six squa- 
mous  cell  carcinomas  were 
fixed in 4 % paraformaldehyde, 
sectioned (5 Ixm), and exposed 
to  anti-hK1  (A,  B,  and  G), 
anti-hK14 (Cand D), and anti- 
hK16 (E,  F, H-J).  Antibody 
localization  was  visualized 
using the  immunogold label- 
ing  and  silver  enhancement 
technique of Janssen Life Sci- 
ences  Products.  Representa- 
tive samples shown were from 
a well-differentiated squamous 
cell carcinoma (A, C, and E), 
a  poorly differentiated  squa- 
mous cell  carcinoma (B,  D, 
and F),  a  moderately differ- 
entiated  squamous  cell  car- 
cinoma  (G  and  H),  actinic 
keratosis  (I),  and  from  the 
epidermis adjacent to a well- 
differentiated  squamous  cell 
carcinoma (J). Note the pres- 
ence of keratinizing squames 
in the  well-differentiated  and 
moderately  differentiated  tu- 
mors and the relative  lack of 
differentiation  and  organiza- 
tion in the  poorly differenti- 
ated sample. Note the relative 
absence of basal-like cells in 
the particular example shown 
of a moderately differentiated 
tumor.  Note also that the ex- 
pression of K1 is largely uni- 
form in all of the cells of this 
tumor, as opposed to that seen 
in the  well-differentiated  tu- 
mor.  Both anti-hK1 and anti- 
hK16 correlated well with ker- 
atinization in SQCC samples. 
Note  the presence of KI6 in 
the  suprabasal  layers  of the 
pre-squamous cell carcinoma 
sample  of  actinic  keratosis. 
Also note the abnormal pres- 
ence of K16 in the epidermis 
adjacent  to  a  well-differen- 
tiated  squamous  cell  carci- 
noma (J). Bar: (A-H) 30 Ixm; 
(I and J) 74 ~tm. 
Stoler et al. Keratin Expression in Epidermal Diseases  433 Figure 6. Anti-keratin staining of basal cell carcinomas. Samples from a superficial l~asal cell carcinoma were fixed in 4% paraformalde- 
hyde, sectioned (5 tim) and exposed to anti-hKl (A), anti-hK14 (frame B), and anti-hKl6 (C). Bound antibodies were visualized by indirect 
immunohistochemistry, using the immunogold enhancement technique as described in Materials and Methods. Sections were examined 
by photomicroscopy. Note the abnormal expression of KI6 in the epidermis adjacent to the tumor (C). The boundaries of the tumor are 
indicated by the dotted line. Bar, 30 Itm. 
Altered Patterns of  Keratin Expression in Specific Cells 
of  Squamous and Basal Cell Carcinomas 
Squamous  cell  carcinomas  (SQCCs) I  are  typified by  the 
presence of transformed,  squamous-like keratinocytes (for 
review,  see  Fitzpatrick  et  al.,  1979).  Well-differentiated 
SQCCs have more organized, basal-like cells at the periph- 
ery of the tumor mass,  and keratinized "pearls" of differ- 
entiated  epidermal  squames  located in  the  center.  Poorly 
differentiated SQCCS  do not show much variation in cell 
morphology. Cells tend to be squamous-like and irregular, 
with little evidence of keratinization or of organized basal 
cells. 
Previously, it was shown that while KI and KI0 expression 
is lower in squamous cell carcinoma tissue, the keratinized 
centers of well-differentiated tumors contain terminal differ- 
entiation-specific keratins (Robinson,  1987; Thomas et al., 
1984). Indeed, when we stained a section of a well-differen- 
tiated SQCC with our anti-hKl  antiserum, K1  was readily 
detected in the keratinized centers (Fig. 5 A). Markedly re- 
duced staining was observed towards the periphery of the tu- 
mor mass, and in the unkeratinized areas of the tumor. The 
association of anti-hKl staining and squamous, keratinized 
morphology was observed in all samples of squarnous cell 
carcinoma that we investigated. Thus, even in poorly differ- 
entiated squamous cell carcinomas, where the expression of 
K1 and KI0 has rarely been detected by gel electrophoretic 
analyses (Weiss  et al.,  1984; Thomas et al.,  1984; Moll et 
al.,  1983,  1984; Breitkreutz et al.,  1981), anti-hKl staining 
could be seen in regions where the squamous morphology 
of tumor cells was greatest (Fig.  5 B).  A  particularly in- 
teresting example of this was in a moderately differentiated 
1. Abbreviation  used in this paper:  SQCC(s), squamous cell carcinoma(s). 
squamous cell carcinoma, where most, if not all of the cells 
of the tumor appeared to be squamous in morphology and 
stained very brightly with anti-hK1 antiserum (Fig.  5  G). 
Our antiserum against hK14 consistently showed promi- 
nent staining throughout all of the cells of each squamous 
cell carcinoma (Fig.  5,  C  and D).  In some cases of well- 
differentiated SQCCs (such as the example in Fig. 5 C), anti- 
hKl4 staining was lower in the basal-like cells than in the 
central, more squamous regions. In other squamous cell car- 
cinoma samples, wide variation in anti-hKl4 staining was of- 
ten observed, but no strong correlation with cell morphology 
could be made. 
Most SQCCs showed patterns of anti-hK16 staining that 
were comparable to those seen for psoriatic tissue. The ex- 
pression of K16 was greatest in well-differentiated tumors 
and seemed to be most prevalent in the squamous (central) 
areas of the carcinoma, with markedly reduced levels in the 
less differentiated (marginal) areas (Fig. 5 E). Poorly differ- 
entiated tumors showed very little anti-hK16 staining, with 
only a few cells staining appreciably above background lev- 
els (Fig. 5 F). Moderately differentiated  tumors showed vari- 
able levels of anti-hKl6 staining: in the example shown (Fig. 
5 H), K16 expression was low. These findings are in agree- 
ment with previous microdissection analyses of squamous 
cell carcinomas (Moll et al.,  1983,  1984), and further em- 
phasize the correlation between anti-hK16 staining and squa- 
mous morphology. 
Interestingly, K16 expression was readily detected in the 
suprabasal layers from the lesions of a patient with actinic 
keratosis, a premalignant hyperproliferative  disease which is 
somewhat similar in appearance to psoriasis, (Fig. 5 I; Fitz- 
patrick et al.,  1979). While anti-hK14 staining was similar 
to that seen in normal epidermis, anti-hK1 staining appeared 
to be somewhat reduced, and its location paralleled the anti- 
The Journal of Cell Biology, Volume 107,  1988  434 Figure 7. In situ localization of K14 mRNA in normal epidermis and psoriatic epidermis. Tissue samples were fixed in 4% paraformalde- 
hyde, sectioned  (5 ~tm) and hybridized with 35S-UTP-labeled cRNA probe complementary  to human K14 mRNA. After hybridization, 
samples were washed, treated briefly with single-stranded RNase, and exposed to an NTB-2 Kodak autoradiographic emulsion as described 
in Materials and Methods. Exposed silver grains were developed after 3 d and samples were stained with hematoxylin and eosin to visualize 
tissue morphology. Sections were examined by photomicroscopy using both brightfield (left) and darkfield (right). Samples were from nor- 
mal epidermis  (A and B) and psoriatic  epidermis  (C-F),  Sample shown in E and F represents a magnified (3.85x) version of an area 
in frame C. Bar:  (A, B, E, and F) 30 gm; (C and D) 74 Ixm. 
hK16 pattern (data not shown). Moreover, in all of the sam- 
ples of squamous cell carcinoma that we investigated, abnor- 
mal expression of K16 was detected in the adjacent regions 
of seemingly  normal  epidermis  (Fig.  5  J).  This  unusual 
phenomenon has been reported previously using a less spe- 
cific antibody (Weiss et al.,  1983).  Whether this abnormal 
expression occurred as a consequence of some extracellular 
stimulus released either by the tumor cells or the surround- 
ing damaged tissue was not determined.  Thus, K16/K6 ex- 
pression occurred in epidermal tissue of various and diverse 
morphologies. The unifying feature of cells expressing these 
keratins seemed to be their suprabasal location and their as- 
sociation with hyperproliferation or trauma. 
The patterns of anti-keratin staining of relatively undiffer- 
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those of squamous cell carcinomas (Fig. 6). K1 appeared to 
be extremely low or absent in most tumor cells (Fig. 6 A). 
In some tumors, K1  was even reduced or absent in two to 
three suprabasal layers of the adjacent epidermis (data not 
shown). In contrast, K14 was present in all of the cells of all 
basal cell carcinomas that we examined (Fig. 6 B). However, 
the levels of K14 staining were variable, and in some tumors, 
K14 expression seemed to be markedly reduced when com- 
pared with the adjacent basal layer. Surprisingly, while K16 
was not detected in any of the basal cell carcinomas that we 
examined, it was abnormally expressed in the adjacent areas 
of epidermis (Fig. 6 C). Hence, although the pattern of kera- 
tin expression throughout the cells of basal cell carcinomas 
seemed to be quite uniform and purely basal-like in charac- 
ter, these tumors caused changes in the differentiation pro- 
cesses in adjacent regions of the epidermis. 
Altered Production of Keratins in Hyperproliferative 
Epidermal Diseases Appears to Be Largely at the Level 
of mRNA Expression 
To examine the correlation between mRNA and protein ex- 
pression for the epidermal keratins, we conducted in situ hy- 
bridization analyses using radiolabeled cRNA probes com- 
plementary to the mRNAs encoding keratins K14, K6a, and 
K16 (Figs.  7-10).  Previously, we had conducted Northern 
blot analysis and in situ hybridizations to verify the specificity 
of these probes (Tyner and Fuchs,  1986; RayChaudhury et 
al.,  1986; Rosenberg et al.,  1988). 
When an  35S-UTP-labeled cRNA  probe complementary 
to a large portion of the coding region of the K14 mRNA was 
hybridized with normal foreskin epidermis, abundant grains 
were localized over the basal layer of normal epidermis, with 
low, but detectable hybridization extending into the spinous 
epidermal layers (Fig. 7, A and B). The dramatic decline in 
KI4 mRNA expression seen during the transit of a normal 
epidermal cell from the basal to the first suprabasal layer was 
also observed in psoriatic tissue (C-F). Once again,  some 
labeling was seen in the spinous layers, and even the outer- 
most epidermal layers showed some hybridization. In both 
normal  and  psoriatic  tissue,  the  down-regulation  of K14 
mRNA expression in the basal-suprabasal transition seemed 
to be more striking than the corresponding decrease in K14 
protein. 
The expression of K14  mRNA  in  squamous  cell carci- 
nomas was quite variable (Fig. 8, A and B). In well-differen- 
tiated regions of the squamous cell carcinomas, clusters of 
tumor cells frequently showed high grain density (e.g., the 
lower right cluster of cells in A and B). Leading portions of 
tumor masses,  especially those near the skin surface, also 
showed high levels of K14 mRNA. This pattern of K14 mRNA 
distribution was similar to that observed in normal epider- 
mis, and was frequent in more organized regions of the tu- 
mor and in cells having the most basal-like appearance (see 
Fig.  8,  C and D, and close-ups in E and F). 
Some masses of SQCC cells showed levels of KI4 mRNAs 
which were substantially lower than the adjacent regions of 
normal epidermis (see for example, the small cluster at the 
upper right in Fig.  8, A and B).  This reduction in keratin 
mRNA expression was also observed for cells of some basal 
cell carcinomas (Fig. 8, G and H; compare basal layer of  over- 
lying epidermis with tumor mass in H). These data suggest 
that the overall level of keratin mRNA expression may be 
significantly down-regulated in some malignant keratinocytes. 
To determine the extent to which transcriptional and post- 
transcriptional controls play a  role in the induction of the 
hyperproliferation-associated keratins in different epidermal 
diseases, we used in situ hybridization with specific radiola- 
beled K6a and K16 cRNA probes to examine the level of K6 
and K16 mRNAs in normal skin, psoriatic skin, and basal 
and  squamous  cell carcinomas.  After hybridizations with 
equal concentrations of radiolabeled probes specific for and 
complementary to (a) the coding portion of the human K6a 
mRNA  and  (b) the  noncoding portion of the human K16 
mRNA, tissue sections were exposed to photographic emul- 
sion for 8 d (normal epidermis) or 3 d (all samples) before 
developing the exposed silver grains (Fig. 9 and 10). As had 
been observed previously (Tyner and Fuchs,  1986), at long 
exposure, K6a mRNA could be detected throughout all of the 
living layers of normal epidermis at a  low, but significant 
level (Fig. 9, A and B). This was true even when a 3' noncod- 
ing probe was used to identify K6a mRNA (Tyner and Fuchs, 
1986; Lersch and Fuchs, 1988). Upon shorter exposures, the 
presence of this mRNA was more difficult to verify (Fig. 9 
C). The expression of K16 mRNA closely paralleled that of 
its partner K6 mRNA in normal epidermis (Fig. 9 D). This 
was also true for other epidermal samples that we examined. 
In psoriatic tissue, the level of K6a mRNA expression was 
greatly elevated over that seen in normal epidermis (Fig. 9, 
E and F). This increase in mRNA was largely confined to 
the spinous layers. An increase in the grain density was also 
observed in the suprabasal layers of psoriatic tissue hybrid- 
ized with the K16 probe (Fig. 9 G). Hence, the increase in 
K16 and K6 mRNAs correlated well with the appearance of 
K16 (and presumably K6) protein in the suprabasal cells of 
psoriatic tissue. 
The expression of K16 and K6 mRNAs was also elevated 
in some squamous cell carcinoma tissues (Fig.  10).  Once 
again,  the  localization of these mRNAs  showed a  pattern 
which was often opposite to that seen for the K14 mRNA 
probe.  In well-differentiated tumors,  K6 and K16 mRNAs 
were  usually  concentrated in  the  inner,  more keratinized 
masses of the tumors, with lower levels in the basal-like cells 
(Fig.  10, A and B).  Lower levels of K6/K16 mRNAs were 
also found in all of the cells of poorly differentiated SQCCs 
(Fig.  10, C and D). However, the levels of expression of K6 
and KI6 mRNAs in at least some of the regions of all squa- 
Figure 8.  In situ localization of K14 mRNA in squamous and basal cell carcinoma. Tissue samples were fixed and subjected to in situ 
hybridization with 35S-UTP-labeled cRNA KI4 probe as described in the legend to Fig. 7. (Left) Brightfield; (right) darkfield. (A and B) 
A well-differentiated squamous cell carcinoma: note wide variability in hybridization for keratinized cells (lower cluster of cells, with strong 
hybridization), less keratinized cells (upper cluster, with weak hybridization) and leading edges of the tumor (at left); (C and D) periph- 
eral regions of a well-differentiated squamous cell carcinoma; (E and F) enlargement (3.85  x) of the area contained within the dotted box 
shown in C; (G and H) a basal cell carcinoma: note that the overall expression of K14 mRNA in this basal cell carcinoma was lower than 
in the basal layer of the epidermis adjacent to the tumor (comparison indicated by the arrows). Bar: (A-D and G and H) 74 gm; (E and 
F) 30 ~tm. 
Stoler et al. Keratin Expression in Epidermal Diseases  437 Figure  9.  In situ localization of K6/K16 mRNAs in normal and psoriatic epidermis. Tissue samples were fixed and subjected to in situ 
hybridization with 3~S-UTP-labeled cRNA probe to either K6 or to K16 as described in the legend to Fig. 7. Samples were from: (A and 
B) normal epidermis hybridized with a K6a probe and exposed for 8 d  (brightfield, A; darkfield, B); (C) normal epidermis hybridized 
with a K6a probe and exposed for 3 d (brightfield); (D) normal epidermis hybridized with a KI6 probe and exposed for 3 d (brightfield); 
(E and F) psoriatic epidermis hybridized with a K6a probe and exposed for 3 d (brightfield, E; darkfield, F); (G) psoriatic tissue hybridized 
with a KI6 probe and exposed for 3 d (brightfield, magnified 2.5 x  over other samples). Note the suprabasal location of K6/K16 mRNAs 
in psoriatic tissue. Bar: (A-D and  G) 30 I.tm; (E and F) 74 p.m. 
The Journal of Cell Biology,  Volume 107, 1988  438 Figure 10. In situ localization of K6/K16 mRNAs in squamous and basal  cell carcinomas. Tissue samples  were fixed and subjected  to in 
situ hybridization with 35S-UTP-labeled cRNA probe to either K6a or to K16 as described in the legend to Fig.  7. Hybridizations were 
similar for both K6a and K16 probes, and only one of the two hybridizations  is shown for each sample.  (A, C, and E) Brightfield;  (B, 
D, and F) darkfield.  (A and B) A well-differentiated  squamous cell carcinoma hybridized with a K6a probe; (C and D) a poorly differentiated 
squamous cell carcinoma hybridized with a K6a probe; (E and F) a basal cell carcinoma, hybridized with a K16 probe. The tumor bound- 
aries in B and D are indicated by the dotted lines. Note that the expression  of K6/K16 mRNAs is high in the inner regions of the squamous 
cell carcinoma, whereas the number of grains in the tumor mass of the basal cell carcinoma was negligible.  Note also that the epidermis 
adjacent to the tumor shows an increase in K16 grain density (indicated by the arrow in F). In E: e, epidermis; d, dermis;  t, basal cell tumor. 
Bar: (A-D) 30 ~tm; (E and F) 74 ~tm. 
mous  cell  carcinomas  were  always higher  than  in  normal 
epidermis. In addition, high levels of K6/K16 mRNA expres- 
sion were observed for the suprabasal squamous cells of the 
actinic keratosis sample that we examined (data not shown). 
Hence an increased expression of  these mRNAs may precede 
the malignant transformation leading to the development of 
squamous cell carcinomas. 
In striking  contrast to  squamous  cell  carcinomas,  basal 
cell carcinomas  showed a  little  or no evidence of K6/K16 
mRNA expression (Fig.  10, E  and F).  However, as can be 
seen by the arrow in Fig.  10 F,, the level of expression of the 
hyperproliferation-associated mRNAs is elevated in the ap- 
parently  normal  epidermis  adjacent  to the tumor  as  com- 
pared with more distant regions. This increase in K6 and K16 
Stoler et al.  Keratin Expression in Epidermal Diseases  439 Table L Summary of  Keratin Protein and mRNA Expression in Human Epidermal Diseases 
K14  K6  KI6 
Anti-hK  1  Anti-hK  14  Anti-hK  16  mRNA  mRNA  mRNA 
Normal  epidermis 
Basal  -  +++++ 
Spinous  + + + +  + + + 
S. corneum  + + + +  - / + 
Psoriatic Epidermis 
Basal  -  ++++ 
Spinous  + +  + + + 
Parakeratinized  + +  + + 
Squamous cell carcinoma 
Well differentiated 
leading edges  -/+  + + + + 
inner,  keratinized  + +/+ + + +  + + + + 
Moderately differentiated  +/+ + +  +/+ + + 
Poorly differentiated  +  + 
Adjacent epidermis 
Basal  -  +++++ 
Spinous-inner  -/+  + + + 
Spinous-outer  + + +  + + + 
S. corneum  + + +  - / + 
Basal cell  carcinoma 







+++++  -/+  -/+ 
++  +  + 
-  ++++  -/+  -/+ 
++++  ++  ++++  +++ 
++  -  _  _ 
-/+  +/++++  -/+  -/+ 
++/++++  +/+++  +++  +++ 
+/+++  +++  ++  ++ 
+  +  +  + 
--  +++++  --/+  --/+ 
+++  ++  ++  ++ 
+++  ++  ++  ++ 
+  --  --  __ 
+/+++  -  +/+++  -/+  -/+ 
-  +++++  -  +++++  -/+  -/+ 
--/+  +++  +++  ++  ++  ++ 
+++  +++  +++  ++  ++  ++ 
+++  -/+  +  -  _  _ 
Wherever slashes are shown, the levels of antibody staining or the expression of mRNAs were variable. In these cases the value at the left of the 
slash indicates the minimum levels detected, while the value at the right of the slash indicates the maximum levels detected. 
mRNA expression in the suprabasal cells of the epidermis 
adjacent to tumor masses was also observed for squamous 
cell carcinoma samples.  Thus, for all of the tumor samples 
that  we examined,  the  spinous-like  cells  which expressed 
KI6 protein also showed a corresponding increase in K6 and 
K16 mRNAs. 
A  summary of the immunohistochemical and in situ hy- 
bridization data obtained for normal, psoriatic,  and tumor 
skin tissue is provided in Table I. K14 mRNA and protein 
expression was most prominent in basal epidermal cells and 
in less differentiated cells of squamous and basal cell carci- 
nomas. K1 expression was seen in terminally differentiating 
cells in epidermis and in keratinized regions of SQCCs, but 
not in basal cell carcinomas. K1  expression was down-reg- 
ulated in psoriatic tissue and in tissue from actinic keratosis. 
Expression of the hyperproliferation-associated keratins was 
limited to the suprabasal cells of psoriatic tissue and actinic 
keratosis tissue, to the squamous, well-differentiated cells of 
squamous cell carcinomas, and to the epidermis surrounding 
a tumor.  Basal epidermal  cells showed no evidence of K6! 
K16 expression at the protein level, and only very low levels 
at the mRNA level. K6/K16 induction in suprabasal cells was 
always accompanied by a  corresponding and  dramatic  in- 
crease in mRNA expression. Whether the low, base level ex- 
pression of K6 and K16 mRNAs observed in normal epider- 
mis might functionally contribute to the early stages of wound 
healing or in the development of epidermal disease remains 
to be determined. 
Morphology and Pattern of  Expression of  Keratins in 
Normal and Squamous Cell Carcinoma Cells Cultured 
on Floating CoUagen-Fibroblast Rafts In Vitro Is 
Parallel to That Seen In Vivo 
When normal human epidermal cells are cultured on colla- 
gen-fibroblast  rafts  that  are  subsequently  (at  confluence) 
floated at the air-medium interface, they stratify extensively 
and undergo many of the biochemical features characteristic 
of terminal differentiation (Fig.  11 A; see also Asselineau et 
al., 1986; Kopan et al.,  1987). These features include the ex- 
pression of low, but significant levels of KI and K10 in the 
suprabasal  layers (Fig.  11 B; Kopan et al.,  1987).  The ex- 
pression of K5/K14 and K16/K17/K6 in epidermal rafts has 
been reported (Asselineau et al.,  1986; Kopan et al.,  1987), 
but it has not been localized. 
When sections of epidermal rafts were stained with anti- 
hK14,  K14  was  detected  throughout the  epidermal  layers, 
with expression being greatest in the basal layer,  but with 
marked  persistance  in  the  suprabasal  layers  (Fig.  11  C). 
When rafts were stained with anti-hK16, K16 was most abun- 
The Journal of Cell Biology, Volume  107,  1988  440 Figure 11. Morphology and keratin expression in floating rafts of cultured human epidermal cells. Epidermal cells were cultured on floating 
rafts as described in Materials and Methods. "Rafts" were fixed in Carnoy's fixative and sectioned (5 lam). Sections were either stained 
with hematoxylin and eosin (A) or subjected to indirect immunofluorescence (B-D) with anti-hK1 (B), anti-hK14 (C), or anti-hK16 (D). 
Dotted line in D indicates the boundary between the epidermal culture and the artificial dermis which in this case did not detach from 
the sample. Bar: (A and D) 30 lam; (B and C) 20 ~m. 
dant in the suprabasal layers (Fig.  11 D). Hence, the pattern 
of keratin expression in epidermal rafts seemed to be very 
similar to that observed for psoriatic tissue (compare with 
Fig. 4), and for epidermis in the vicinity of either squamous 
or basal cell tumors (compare with Figs.  5 and 6). 
The finding that raft cultures of normal epidermal cells in 
vitro are similar to hyperproliferating epidermis in vivo led 
us  to  wonder whether SQCC  lines  grown on  rafts might 
display morphological and biochemical features related to 
SQCCs in vivo. To test this possibility, the SQCC lines SCC- 
12 (facial epidermis), SCC-15 (tongue), and SCC-13 (facial 
epidermis) were cultured on floating lattices of collagen and 
fibroblasts for 10-14 d.  Sections of these cultures revealed 
marked disorganization of the cells within the "tissues" and 
clear evidence of abnormal keratinization (Fig.  12,  A-C). 
Each tumor line exhibited basal-like, spinous-like, and gran- 
ular-containing cells (BL,  SP, and GR in Fig.  12 C); how- 
ever, the differentiative process varied greatly for each line. 
The SCC-12 line was interesting in that it seemed to invade 
the collagen-fibroblast layer, with epidermal growth extend- 
ing deep into this  lattice (Fig.  12 A).  The other two lines 
showed little or no evidence of this behavior, but nonetheless 
had morphologies which were clearly abnormal (Fig.  12, B 
and C). In all three lines, a number of mitotic cells could be 
observed even in the outermost layers of some of the sections. 
To examine the pattern of keratin expression, sections of 
SCC-13 rafts were stained with anti-keratin antisera.  SCC 
rafts were unusual  in that they showed only patchy stain- 
ing with anti-hK1 (Fig.  12, D and E). This keratin was re- 
stricted to suprabasal cells, and staining was most abundant 
in the central regions of the raft (Fig.  12 D). Less-stratified 
regions showed less K1 expression, which was also restricted 
to the suprabasal cells located in the centers, rather than the 
growing edges of these areas (Fig.  12 E). In well-stratified 
portions of the raft, K14 protein was detected in all layers, 
with strongest staining in the inner layers (see Fig.  12 F). 
In less-stratified portions on the raft, K14 expression seemed 
to be most abundant in the inner and outer layers of the tissue 
(Fig.  12 G). 
The pattern of K16 expression in SCC-13 rafts was similar 
to that  obtained  for K1  (Fig.  12,  H  and  I).  Hence,  only 
suprabasal  cells  showed  K16  staining,  and  this  was  most 
prominent in more stratified regions of the culture (Fig.  12 
H).  In  most cases,  poorly stratified areas  at  the growing 
edges of the raft cultures showed little or no K16 staining 
(Fig.  12 I). 
Stoler  et  al.  Keratin  Expression in Epidermal Diseases  441 Figure 12. Morphology and keratin expression in floating rafts of cultured human squarnous cell carcinoma lines. Keratinocytes from squa- 
mous cell carcinoma lines of skin, SCC-12 and SCC-13, or tongue, SCC-15, were cultured on floating rafts as described in Materials and 
Methods.  Rafts were fixed in Carnoy's fixative and sectioned (5 I~m). Sections were either stained with hematoxylin and eosin (A-C) or 
subjected to indirect immunofluorescence (D-l) with anti-hKl  (D and E), anti-hKl4  (F and G), or anti-hK16 (H and I). Samples were 
from rafts of: SCC-12 (A), SCC-13 (Cand D-I), and SCC-15 (B). In D-l, the left portion of  each panel shows staining of  a well-differentiated 
portion of the raft; the right portion shows staining of the growing edge of the raft. BL, basal-like cells; SP, spinous-like cells; and GR 
granulocytes.  Bar: (A-C, E, G, and I) 30 Ixm; (D, F, and H) 40 gm. 
Collectively, our studies indicate that certain morphologi- 
cal and biochemical features of the terminal differentiation 
process are maintained in squamous cell carcinoma cultures, 
but that the process is grossly abnormal when compared with 
primary epidermal cultures (Fig.  11). In all cases, both K1 
and K16 were detected,  and their expression seemed to be 
greatest in the squamous, more stratified regions of the rafts. 
These results are in good agreement with the findings ob- 
tained for SQCCs in vivo and suggest that the raft system 
closely  approximates  the  morphological  and  biochemical 
aberrations  of SQCCs.  Whether  this  culture  method  will 
provide a parallel between the degree of differentiation of an 
SQCC in situ and the morphology of the corresponding tu- 
mor line in vitro awaits more careful analyses using primary 
SQCC cells from a  number of different SQCCs. 
The Journal of Cell Biology. Volume  107, 1988  442 Discussion 
Do the Monospecific  Antisera Detect Their Keratins in 
All Epidermal Cells Where They  Are Present? 
One  of  the  major  concerns  with  immunohistochemical 
studies is whether a negative result represents the absence or 
the masking of a protein. For the keratins, masking of anti- 
genic sites has already been observed in some in vivo studies 
(Woodcock-Mitchell et al.,  1982;  Weiss et al.,  1984). 
Physicochemical studies on keratins have suggested that 
the nonhelical end domains of  the polypeptides may protrude 
along the  surface of the keratin filament (Steinert et al., 
1983; 1985; Roop et al., 1984; Albers and Fuchs, 1987), in- 
dicating that these domains might provide the best antigenic 
sites to guard against antibody masking. Since the carboxy 
terminus is also the most highly divergent region of the kera- 
tin polypeptide, this region seemed to be most suitable candi- 
date for the production of monospecific anti-keratin anti- 
bodies. 
Our studies involving anti-hK14 have indicated that not 
only is this antiserum monospecific for K14, but in addition, 
it seems to detect K14 where it is present. This antiserum 
demonstrated clearly the abundant expression of K14 in the 
basal epidermal layer, with extension of expression to the 
suprabasal cells as well. While tissue-sectioning experiments 
(Fuchs and Green,  1980;  Woodcock-Mitchell et al.,  1982) 
and mRNA analyses (Tyner and Fuchs, 1986) have suggested 
that expression  of K14 might continue in the  suprabasal 
layers, previous studies with other antibodies have not been 
able to verify this notion. 
In this report, we have shown that our anti-hK1 antiserum 
is  also monospecific, and the K1  expression patterns ob- 
tained  with  this  antiserum  are  consistent  with  previous 
mRNA studies (Fuchs and Green,  1980),  tissue-sectioning 
experiments (Fuchs and Green,  1980;  Woodstock-Mitchell 
et al., 1982), and immunohistochemical studies (Viac et al., 
1980; Woodcock-Mitchell et al., 1982). Although we cannot 
be unequivocally certain that the anti-hK1 antigenic site is 
exposed in all cells of epidermal diseases, the patterns of ex- 
pression which we observed with the antiserum are consis- 
tent with our data on normal epidermis and indicate thatK1 
is only expressed in terminally differentiating cells. 
The presence of anti-hK1  staining in all suprabasal layers 
of human skin, including the s. corneum, is somewhat differ- 
ent from that seen with an anti-mouse K1 peptide antiserum 
which showed only spinous and granular layer staining of 
mouse skin (Roop et al., 1984).  This difference may be due 
to the fact that the anti-mouse K1 antiserum was prepared 
against the extreme carboxy-terminal tridecapeptide of the 
mouse K1, whereas our anti-human K1 antiserum was pre- 
pared against a 17-mer located just to the carboxyl side of the 
L L E G E alpha-helical sequence (see Fig.  1). Previously, 
it was observed that posttranslational processing of the 67- 
kD K1 to a 65-kD by-product (possibly K2) takes place in 
the outer layers of human skin (Fuchs and Green,  1980). 
Collectively, the data suggest that at least some of the resi- 
dues following the L L E G E sequence in K1 are retained 
in the s. corneum layers, while the carboxy terminus may be 
lost. 
Before our study, little was known about the pattern of ex- 
pression of K6/K16 in cultured epidermal cells or in epider- 
mal diseases of hyperproliferation. Early studies on keratin 
expression in cultured keratinocytes indicated that the cells 
were largely basal-like in character, and led to initial specu- 
lation that all four cultured cell keratins (K5, K6, K14, and 
K16) might be expressed in basal epidermal cells (Fuchs and 
Green,  1980).  More recent studies have indicated that K6/ 
K16 are not present in normal epidermis and when they are 
expressed  (e.g.,  during hyperproliferation or  in  culture), 
they may have a suprabasal location. In one such study, cell 
separation of cultured rabbit corneal epithelial cells  sug- 
gested a suprabasal location (Schermer et al., 1986). Several 
other studies using the monoclonal antibody AE1  showed 
only basal staining of  normal epidermis (Woodcock-Mitchell 
et al.,  1982),  but basal and spinous staining of psoriatic 
epidermis (Weiss et al., 1984). Since the repertoire of kera- 
tins cross-reacting with AE1 include K16 and since K16 is 
an induced component of the psoriatic cytoskeleton, it was 
suggested that K16 might be preferentially localized in the 
suprabasal layers of  psoriatic skin (Weiss et al., 1984). How- 
ever, because AE1 also cross reacts with K10 and K14 in the 
epidermis,  and because  the  antigenic determinant recog- 
nized by AE1 is known to be masked for both K14 and K10 
in the suprabasal cells of normal epidermis, but unmasked 
for K14 in the basal layer, the use of this antibody as a tool 
to identify the presence or absence of a particular keratin 
could not be made with certainty. 
Our finding that the hK16 antiserum cross reacts with the 
cytoskeleton of suprabasal  cells of psoriatic  epidermis  is 
consistent with the early predictions by Weiss et al. (1984). 
While possibilities of masking cannot be excluded with anti- 
hK16, they are less likely considering that (a) the antiserum 
is polyclonal, and (b) the antiserum is against the carboxy- 
terminal end of the polypeptide chain. The increased levels 
of K16 and K6 mRNAs in the suprabasal layers of psoriatic 
epidermis support the immunohistochemical localization of 
these proteins. 
K1 Localization, Cell Morphology, and 
Terminal Differentiation 
The association of K1 and its partner K10 with the process 
of  terminal differentiation  has been well documented for nor- 
mal epidermis (for review, see Fuchs et al., 1987). Their lo- 
calization in SQCC  has been more difficult to determine 
due to the irregular morphology of the tumors, and at pres- 
ent,  the  data  have  yielded  somewhat conflicting results. 
While  the  microdissection studies  of Moll  et  al.  (1983) 
showed no correlation between the presence of K1/K10 and 
the  appearance  of highly keratinized pearls  within well- 
differentiated SQCCs, the immunohistochemical studies of 
Thomas et al. (1984) and Robinson (1987) indicated that the 
terminal differentiation-specific keratins are most abundant 
in SQCC-pearls. Our monospecific antiserum against human 
K1 (anti-hK1), has provided evidence that supports the previ- 
ous immunohistochemical  results. Moreover, the correlation 
between K1 expression and squamous-like morphology ex- 
tends even to a moderately differentiated squamous cell car- 
cinoma where all of the cells of the tumor appeared squa- 
mous in character and expressed K1. 
KI4 Expression and Basal-like Morphology 
While K1 expression is strongly associated with squamous- 
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pression of the K14/K5 pair of keratins appears to be a major 
feature of all basal-like cells,  Hence, both in vivo and in 
vitro, K14 seems to be the only type I protein expressed in 
the  basal  cells  of  both  normal  and  hyperproliferating 
epidermis, and in the basal-like cells of basal and squamous 
cell carcinomas. A high level of K14 mRNA also seems to 
correlate with a basal-like character.  However,  while K14 
mRNAs are abundant in basal cells of normal and psoriatic 
tissue, their expression varies considerably in tumor cells. 
Whether the low level of K14 expression in the basal-like 
cells of some tumors reflects a less differentiated state than 
true basal cells of adult epidermis remains to be determined; 
however, it is interesting to note that some basal cell carci- 
nomas seem to be less differentiated in that islands of tumor 
cells can develop into hair and glandular-like structures, a 
capacity that is normally lost early during embryonic devel- 
opment (Fitzpatrick et al.,  1979). 
K6/K16 Expression and Suprabasal Cells 
A major finding of our studies is that only suprabasal cells 
express  K6  and  K16  during  hyperproliferation  in  the 
epidermis. This was true for psoriatic tissue, actinic kerato- 
sis, and regions of epidermis adjacent to tumors. Even in 
SQCCs, only the more squamous-like cells rather than the 
basal-like cells, expressed K6/K16. Moreover, the induction 
of K6/K16 expression in hyperproliferating epidermal cells 
seemed to coincide with a  down-regulation in K1/K10 ex- 
pression. Our investigations revealing the opposing behavior 
of K6/K16 and K1/K10 in the  suprabasal  cells of hyper- 
proliferating epidermis provide direct experimental evidence 
in  support  of  earlier  hypotheses  (Weiss  et  al.,  1984; 
Schermer et al.,  1986). 
The detection of K6/K16  in all and only the suprabasal 
cells of hyperproliferative diseases such as psoriasis revealed 
a  marked biochemical distinction between the  basal  and 
suprabasal cells. This distinction was further illuminated by 
(a) the uniform decrease in K1 expression in all suprabasal 
cells, and (b) the presence of high levels of K14 mRNAs in 
only the basal cells. Our data is also in agreement with that 
of Leigh et al.  (1985),  who examined other biochemical 
markers of basal and suprabasal psoriatic cells. It could be 
that the pattern of keratin gene expression in basal cells is 
controlled by the particular differentiation-state of an epider- 
mal cell. Alternatively, the pattern of  keratins might be deter- 
mined by the close association of basal cells either with the 
basement membrane or with the dermis. In either case, the 
increased population of cells in psoriatic epidermis does not 
seem to express markers typical of  basal epidermal cells, and 
yet they differ from normal spinous cells in their expression 
of  K6/K16  and  in  their  reduced  expression  of K1/K10. 
Whether these biochemical differences contribute to the in- 
creased proliferative rate of the  suprabasal  population in 
psoriasis (Lavker and Sun, 1983; Weinstein and Van Scott, 
1965;  Leigh et al.,  1985) remains to be determined. 
If basal epidermal cells do not produce K6/K16, then a pri- 
ori, we would not expect undifferentiated basal cell carci- 
nomas to express these keratins. In fact, none of the four 
samples of solid or superficial basal cell carcinomas inves- 
tigated in our study showed appreciable staining with our 
anti-hK16 antiserum, nor did they express significant levels 
of K6 or K16 mRNAs. Thus, it seems most likely that the 
occasional report of either significant  or trace amounts of K6 
and K16 in basal cell carcinomas (Moll et al., 1982b,  1983, 
1984;  Breitkreutz et al.,  1981; Kubilus et al.,  1980;  Weiss 
et al., 1984) reflects either (a) the detection of induced K16 
and K6 in adjacent epidermis contaminating the tumor sam- 
ple, or (b) a basal cell tumor capable of undergoing some, 
perhaps  limited or altered,  form of differentiation. More 
comprehensive studies using our antisera and cRNA probes 
to investigate additional basal cell carcinomas should help to 
clarify the extent to which basal cell carcinoma cells might 
be able to express K6/K16. 
K6/K16 Expression May Be Regulated at Both the 
Transcriptional and the Posttranscriptional Levels 
Previously, we had shown that K6 mRNAs are present at a 
low level throughout normal epidermis even though no K6 
protein is detected (Tyner and Fuchs,  1986).  These RNAs 
seem to be  translatable in a  reticulocyte lysate system in 
vitro, and they are also of the proper size (Tyner and Fuchs, 
1986). Thus, posttranscriptional controls seem to be operat- 
ing to prevent the synthesis of K6/K16 in normal epidermis. 
However,  when  epidermis  is  placed  into  tissue  culture 
medium, an increase of up to ninefold is seen in K6 mRNA 
levels,  indicating that additional (possibly transcriptional) 
controls might also be important in regulating the expression 
of these keratins (Tyner and Fuchs,  1986). 
Our initial studies led us to wonder whether the induction 
of hyperproliferation-associated keratins in psoriasis and in 
squamous cell carcinomas is accompanied by an increase in 
their mRNAs, or alternatively, whether changes in the trans- 
latability of existing mRNAs might dominate. Our results 
have clearly demonstrated that in both diseases, the levels of 
K16 and K6 mRNAs are greatly elevated in the cells that are 
induced to express these keratins. Thus, both in normal skin 
placed  in  culture  medium  and  in  epidermal  diseases  of 
hyperproliferation, a substantial increase in K6/K16 mRNA 
levels  takes  place  concomitantly  with  the  induction  of 
K6/K16 expression. Since these changes take place only in 
the  suprabasal  epidermal  cells,  it  is  likely  that  only 
suprabasal cells have the capacity to sense the external stimu- 
lus that triggers the hyperproliferative response. 
We do not yet know whether the low levels of K16 and K6 
mRNAs  observed  in  normal epidermis  are  functional in 
vivo.  Posttranscriptional controls might enable the hyper- 
proliferative response to occur more rapidly than if regula- 
tion is strictly at the transcriptional level. If expression of K6 
and K16 is important, either to create a cytoskeleton more 
compatible with cell division, or to enable a greater number 
of divisions to occur before terminal differentiation, then 
recruiting premade mRNAs to produce these keratins might 
facilitate the  response.  However,  even  if a  base  level  of 
mRNA expression is important to the initial events leading 
to hyperproliferation, the maintenance of the response seems 
to be fulfilled by a mechanism that leads to a large increase 
in the pool size of K6/K16 mRNAs. Further studies using 
both in vivo and in vitro models of epidermal hyperprolifera- 
tion should help to elucidate the molecular mechanisms un- 
derlying this complex and fundamentally important biologi- 
cal response. 
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